Race Oncology Limited (ASX:RAC)
Australia
· Delayed Price · Currency is AUD 1.220
+0.010 (0.83%)
Feb 21, 2025, 3:58 PM AEST
Race Oncology Revenue
In the fiscal year ending June 30, 2024, Race Oncology had annual revenue of 4.00M AUD with 27.73% growth.
Revenue
4.00M
Revenue Growth
+27.73%
P/S Ratio
50.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
211.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 4.00M | 869.09K | 27.73% |
| Jun 30, 2023 | 3.13M | 2.43M | 342.83% |
| Jun 30, 2022 | 707.81K | 320.42K | 82.71% |
| Jun 30, 2021 | 387.39K | 228.01K | 143.07% |
| Jun 30, 2020 | 159.37K | -69.13K | -30.25% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 16.66B |
| Ansell | 3.00B |
| Mesoblast | 8.85M |